Skip to content

Pulsar-18 T3 6/100/90Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130446601), received between Sep 1, 2020 and Sep 1, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Labelling, Instructions for Use or Training Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Labelling, Instructions for Use or Training Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 1, 2020Labelling, Instructions for Use or Training Problem; Labelling, Instructions for Use or Training Problem

    A PULSAR-18 T3 PERIPHERAL STENT SYSTEM WAS SELECTED FOR TREATMENT. DURING THE PROCEDURE THE INNER UNSTERILE POUCH WAS HANDED TO THE SCRUB NURSE AND PLACED ONTO THE STERILE FIELD. THEN THE INNER UNSTERILE POUCH WAS OPENED UP ON THE STERILE FIELD, THE STERILE TRAY WAS REMOVED AND THE DEVICE WAS IMPLANTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10478573 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page